Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Liabilities and Shareholders Equity (2017 - 2025)

Historic Liabilities and Shareholders Equity for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to $25.5 million.

  • Catheter Precision's Liabilities and Shareholders Equity fell 475.6% to $25.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.6 million, marking a year-over-year decrease of 729.85%. This contributed to the annual value of $27.8 million for FY2024, which is 964.99% down from last year.
  • As of Q3 2025, Catheter Precision's Liabilities and Shareholders Equity stood at $25.5 million, which was down 475.6% from $25.6 million recorded in Q2 2025.
  • Catheter Precision's Liabilities and Shareholders Equity's 5-year high stood at $48.5 million during Q1 2023, with a 5-year trough of $14.4 million in Q2 2022.
  • Over the past 5 years, Catheter Precision's median Liabilities and Shareholders Equity value was $26.3 million (recorded in 2024), while the average stood at $26.7 million.
  • In the last 5 years, Catheter Precision's Liabilities and Shareholders Equity tumbled by 5070.82% in 2022 and then soared by 14728.31% in 2023.
  • Catheter Precision's Liabilities and Shareholders Equity (Quarter) stood at $21.0 million in 2021, then dropped by 20.0% to $16.8 million in 2022, then soared by 82.56% to $30.7 million in 2023, then fell by 9.65% to $27.8 million in 2024, then decreased by 8.27% to $25.5 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $25.5 million for Q3 2025, versus $25.6 million for Q2 2025 and $24.8 million for Q1 2025.